Wednesday, February 15, 2017 5:32:49 PM
New talk on human drug development by veterinary trials for novel pain therapies BY Steven Kamerling, Therapeutic Area Head for Pain, Inflammation and Oncology at Zoetis. Details on the talk this May at Pain Therapeutics 2017 are available at http://www.pain-therapeutics.co.uk/ihub
Recent ZTS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 08:37:50 PM
- Zoetis to Participate in Upcoming Investor Conferences • Business Wire • 05/21/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:23:35 PM
- Zoetis Declares Third Quarter 2026 Dividend • Business Wire • 05/20/2026 08:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:26:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 11:05:34 AM
- Zoetis Announces First Quarter 2026 Results • Business Wire • 05/07/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:23:49 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 06:47:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/13/2026 10:02:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/13/2026 10:02:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/13/2026 10:02:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/13/2026 10:02:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/13/2026 10:02:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/13/2026 10:02:05 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/08/2026 01:02:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/08/2026 01:01:42 PM
- Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results • Business Wire • 04/02/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 08:29:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:46:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:46:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:46:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:46:29 PM
